| Revenue growth | 7.82% YoY |
|---|---|
| Margins | EBITDA margin at 8.55%; PAT margin at 3.87%. |
| Demand visibility | Strong domestic demand; 94.26% revenue from domestic markets. |
| Management confidence | High; focusing on diversification and sustainable growth. |
Growth
Revenue grew 7.82% YoY to ₹14,153.72 lakhs; PAT increased by 15.47% YoY to ₹552.26 lakhs.
Outlook
Planned Atrazine manufacturing project target: ₹120-140 crore additional annual revenue. Commencing 15 TPD CBG project operations in FY27.
Risks
High working capital requirements impacting export market capture; exposure to hazardous products and global political/environmental disturbances.
Earnings Call filed with NSE, NSE: DHANSA. Summary written with AI assistance from the document.
Dhansa Labs Ltd: key numbers
- Share price
- ₹28.20
- Market cap
- ₹75.87 Cr
- Revenue (annual)
- ₹141.5 Cr
- Net profit (annual)
- ₹5.73 Cr
- P/E (TTM)
- 13.2×Sector 36.8×
- Promoter holding
- 65.05%-5.10% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhansa Labs Ltd
All →Dhansa Labs Annual General Meeting
Dhansa Labs Limited held its 41st Annual General Meeting on September 26, 2026, to adopt financial statements and ratify the cost auditor's remuneration.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited announced the voting results for its postal ballot. Shareholders approved the alteration of the object clause, asset mortgage/disposal, and a related party transaction.
Dhansa Labs Annual General Meeting
Dhansa Labs Limited issued a notice for its Annual General Meeting scheduled for September 26, 2026. Agenda items include financial statement adoption and director reappointment.
- Value
- ₹0.01 Cr
Dhansa Labs Annual General Meeting
Dhansa Labs Limited approved the notice for its 41st Annual General Meeting and the Director's Report for the financial year ending March 31, 2026.
Dhansa Labs Business Update
Dhansa Labs' wholly owned subsidiary, Dhansa Green Energy, conducted the groundbreaking ceremony for a 15 TPD Compressed Biogas project in Rajasthan.
Dhansa Labs Capital Structure Change
Dhansa Labs received listing and trading approval for 19,56,521 equity shares allotted upon conversion of warrants on a preferential basis.